Amarantus licenses a blood test under development to identify Alzheimer's; Biocartis launched its Dynamic Multi-Analyte Technology platform;

> Amarantus BioScience exercised an option to license a blood test under development designed to identify Alzheimer's at an early stage. Story

> NeuroQuest is moving toward a validation trial for novel blood-based immune biomarkers for the diagnosis of Alzheimer's disease.  Release

> Scientists have discovered a cognitive biomarker for young adolescents who are at high risk of developing depression and anxiety. Report

> Biocartis launched a new proteomic and nucleic acid platform for high quality data analysis and accurate and fast validation of biomarkers. Release

And Finally... Queen Mary, University of London, received a $1.3 million grant through the Biomarkers of Gut Function and Health program to carry out work in Zambia aimed at finding and evaluating candidate biomarkers of enteropathy. Article